Piramal Healthcare, engaged in the manufacturing and sale of own and traded bulk drugs and formulations, has reported 17.72 per cent fall in consolidated net profit at Rs 59.87 crore during the third.
Piramal Healthcare, engaged in the manufacturing and sale of own and traded bulk drugs and formulations, has reported 17.72 per cent fall in consolidated net profit at Rs 59.87 crore during the third.
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Jan 23 2009 | 12:00 AM IST